Skip to main content
. 2015 Jun 4;2015(6):CD010446. doi: 10.1002/14651858.CD010446.pub2

Yin 2011.

Methods

  • Study design: open RCT

  • Study duration: 3 months

  • Follow‐up: 3 months
Participants

  • Country: China

  • Number: treatment group 30; control group 28

  • Sex: female
Interventions Treatment group

  • Intervention

    • Sanjin tablet for 3 months

  • Control

    • low dose antibiotics for 3 months
Outcomes

  • After treatment, the CD3+, CD4+ T cells and CD4+/CD8+ in peripheral blood of the treatment group were enhanced compared with untreated and the control group (P < 0.05)

  • Recurrence rate of the treatment group were significantly better than the control group (P < 0.01)
Notes Authors were contacted to request further information about methods applied to measure clinical outcomes as opposed to assessing immune parameters and bacteriuria